Avian flu toll at 43
- Written by E.Tsiliopoulos
The mutated avian flu virus is on its sixth week and according to new evidence presented by the Greek Center for Disease Control, it has already claimed 43 lives.
Everyday more people are being admitted to hospital ICUs with severe symptoms of the virus, a mutation of the H1N1 strain. Doctors and GCDC officials are urging people from high risk groups, such as elders, asthmatics, children and pregnant women, to get the anti-flu shot, which is out since last November.
In the last few days alone, there were 8 casualties due to the virus. On Monday, three people were admitted to ICUs – two in Thessaloniki and one in Athens. Doctors stress the anti-flu shot is still applicable, since the virus is expected to last until May this year.
Some doctors have their doubts concerning the efficiency of the vaccine. They claim that the recent virus mutations have all but rendered most medicine ineffective. Things get more alarming when these doctors believe it will take quite some time before any new medicine battling the new strain comes out.
Either way, better safe than sorry. All doctors agree that if you belong to a high risk group, you should get the shot. If you get any typical flu symptoms, you should contact your physician immediately and follow his instructions to the letter.
Related items
- Mitsotakis-Erdogan Meeting in Ankara Fixed for May 13
- Hatzidakis in Washington for IMF and World Bank meetings
- Erdoğan flies off the bat: "Israel surpassed Hitler, it is a state of terrorists"
- IMF: Reduction of Greek public debt to 158.8% of GDP in 2024—Primary surplus of 2.1%
- PM Mitsotakis from Brussels: EU aims to prevent Middle East crisis escalation
Latest from E.Tsiliopoulos
- Mitsotakis-Erdogan Meeting in Ankara Fixed for May 13
- Turks flock to Greek islands after vis-on-arrival process
- Hatzidakis in Washington for IMF and World Bank meetings
- Erdoğan flies off the bat: "Israel surpassed Hitler, it is a state of terrorists"
- IMF: Reduction of Greek public debt to 158.8% of GDP in 2024—Primary surplus of 2.1%